Literature DB >> 17879962

Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.

Sara Santana Nunes1, Marianna A Ferrari do Outeiro-Bernstein, Luiz Juliano, Francisco Vardiero, Helena B Nader, Anne Woods, Chantal Legrand, Verônica Morandi.   

Abstract

Thrombospondin-1 (TSP-1) is an extracellular matrix protein that modulates focal adhesion in mammalian cells and exhibits dual roles in angiogenesis. In a previous work, we showed that a recombinant 18 kDa protein encompassing the N-terminal residues 1-174 of human TSP-1 (TSP18) induced tubulogenesis of human umbilical vein endothelial cells and protected them from apoptosis. Our results indicated that these effects were possibly mediated by syndecan-4 proteoglycan, since binding of TSP18 to endothelial extracts was inhibited by anti-syndecan-4 antibody. Syndecan-4 is a heparan-sulfate proteoglycan that regulates cell-matrix interactions and is the only member of its family present in focal adhesions. In this report, we demonstrate that a monoclonal antibody against syndecan-4 blocks TSP18-induced tubulogenesis. Furthermore, through 2D adhesion and 3D angiogenic assays, we demonstrate that two sequences, TSP Hep I and II, retain the major pro-angiogenic activity of TSP18. These TSP-1 motifs also compete with the fibronectin Hep II domain for binding to syndecan-4 on endothelial cell surface, indicating that they may exert their effects by interfering with the recognition of fibronectin by syndecan-4. Additionally, TSP18 and its derived peptides activate the PKC-dependent Akt-PKB signaling pathway. Blockage of PKC activation prevented HUVEC spreading when seeded on TSP18 fragment, and on TSP Hep I and TSP Hep II peptides, but not on gelatin-coated substrates. Our results identify syndecan-4 as a novel receptor for the N-terminus of TSP-1 and suggest that TSP-1 N-terminal pro-angiogenic activity is linked to its capacity of interfering with syndecan-4 functions in the course of cell adhesion. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17879962     DOI: 10.1002/jcp.21281

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  Dual Encapsulated Dacarbazine and Zinc Phthalocyanine Polymeric Nanoparticle for Photodynamic Therapy of Melanoma.

Authors:  Sara Rhaissa Rezende do Reis; Edward Helal-Neto; Aline Oliveira da Silva de Barros; Suyene Rocha Pinto; Filipe Leal Portilho; Luciana Betzler de Oliveira Siqueira; Luciana Magalhães Rebelo Alencar; Si Amar Dahoumane; Frank Alexis; Eduardo Ricci-Junior; Ralph Santos-Oliveira
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

Review 2.  Thrombospondin-1 Signaling Through the Calreticulin/LDL Receptor Related Protein 1 Axis: Functions and Possible Roles in Glaucoma.

Authors:  Joanne E Murphy-Ullrich
Journal:  Front Cell Dev Biol       Date:  2022-05-27

Review 3.  The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.

Authors:  Anguo Liu; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Microvasc Res       Date:  2008-10-01       Impact factor: 3.514

Review 4.  Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.

Authors:  Khushboo Gulati; Krishna Mohan Poluri
Journal:  Glycoconj J       Date:  2015-12-03       Impact factor: 2.916

5.  Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis.

Authors:  Manuel A Pallero; Carrie A Elzie; Jiping Chen; Deane F Mosher; Joanne E Murphy-Ullrich
Journal:  FASEB J       Date:  2008-07-24       Impact factor: 5.191

6.  Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system.

Authors:  Subhamoy Das; Gunjan Singh; Aaron B Baker
Journal:  Biomaterials       Date:  2013-10-16       Impact factor: 12.479

Review 7.  Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion.

Authors:  Jelena Grahovac; Alan Wells
Journal:  Lab Invest       Date:  2013-11-18       Impact factor: 5.662

8.  Genomic and proteomic analysis of the impact of mitotic quiescence on the engraftment of human CD34+ cells.

Authors:  Brahmananda Reddy Chitteti; Yunlong Liu; Edward F Srour
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

Review 9.  Revisiting the matricellular concept.

Authors:  Joanne E Murphy-Ullrich; E Helene Sage
Journal:  Matrix Biol       Date:  2014-07-24       Impact factor: 11.583

10.  The interaction of Thrombospondins with extracellular matrix proteins.

Authors:  Kemin Tan; Jack Lawler
Journal:  J Cell Commun Signal       Date:  2009-10-16       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.